Investigative Medicine Division
We aim to rapidly translate innovative science into patient benefit across a range of disease areas. From molecular biology and target discovery, through to interventional medicine and informing policy, we bring together researchers in a diverse range of specialties including acute stroke, dementia and immunology.
Head of Division
Latest publications
-
Advancements in pathogen immunity and signaling.
Journal article
Gyrd-Hansen M. et al, (2024), Nat Immunol
-
A holistic approach to maternal mental health: beyond epidural analgesia.
Journal article
Kothari T. et al, (2024), Anaesthesia
-
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study.
Journal article
Chanchlani N. et al, (2024), Lancet Gastroenterol Hepatol, 9, 521 - 538
-
HSV-1 employs UL56 to antagonize expression and function of cGAMP channels.
Journal article
Blest HTW. et al, (2024), Cell Rep, 43
-
Oxford Spine Buddies: an acceptability and feasibility project for peer-to-peer support in a spine sarcoma service.
Journal article
Cammas J. et al, (2024), Br J Nurs, 33, S16 - S20
COVID-19 research
Novel all-in-one vaccine developed to tackle future coronavirus threats
6 July 2022
Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.
Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
1 December 2021
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
What's new
Welcome to the new RDM Visiting Professors
27 November 2023